Added to YB: 2024-12-12
Pitch date: 2024-11-19
ECOR [bullish]
electroCore, Inc.
-53.43%
current return
Author Info
No bio for this author
Company Info
electroCore, Inc., a bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation (“nVNS”) technology platform in the United States, the United Kingdom, and internationally.
Market Cap
$36.9M
Pitch Price
$10.20
Price Target
N/A
Dividend
N/A
EV/EBITDA
-3.08
P/E
-3.21
EV/Sales
1.26
Sector
Health Care Equipment and Supplies
Category
growth
Starting Five Virtual #2 - Kyle Adams Finds Bright Spot Amidst Personal Challenge; Medical Device Pitch - $ECOR
ECOR: Non-invasive vagus nerve stimulation for migraines, PTSD, stress. 70% CAGR, VA main revenue. Truvaga B2C growing 100% YoY. TaxStim for military. 86% margins. Near breakeven at $8.5M/qtr. Inflection to profitability in H1 2025. 200+ patents, FDA approved. Potential multibagger at 4x EV/S.
Read full article (18 min)